Skip to content
Close
Oct 21, 2026
Market cap
$116.98M
243.7M shares
Filings
1,022
$10.62M
Q3 2026+726.7% FY25 yoy
-$17.69M
Q3 2026N/M FY25 yoy
-$17.28M
Q3 2026N/M FY25 yoy
$1.30M
Q3 2026derivedN/M FY25 yoy
$0.02
Q1 2026N/M FY25 yoy
$35.12M
Q3 2026+113.3% FY25 yoy
$116.98M
4.0×
0.6×
1.8×
27.33%
—

Twelve months to Sep 30, 2026 · derived

Price

$0.48+33.33%+$0.12past year
Oct 21, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$237.26MFY 2025
$237.26M0FY 2015FY 2020FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$237,258,000reported
FY 20242024-12-31$28,700,000reported
FY 20232023-12-31$7,379,000reported
FY 20222022-12-31$107,000reported
FY 20212021-12-31$892,000reported
FY 20202020-12-31$4,046,000reported
FY 20192019-12-31$9,862,000reported
FY 20182018-12-31$4,159,000reported
FY 20172017-12-31$5,839,000reported
FY 20162016-06-30$9,300,000reported
FY 20152015-06-30$24,600,000reported

Capital returns

Dividends and buybacks · FY2009 to FY2012
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2012—$400.00K$400.00K—22.71M sh−47.0%—
FY2011—$700.00K$700.00K—42.89M sh——
FY2010—$42.77M$42.77M———107.5%
FY2009—$7.94M$7.94M———127.8%

Segments

Products
Revenue by Products, FY2018 to FY2024FY2018Government Contract · FY2018 · $1.34MNon Cash Royalty Revenue · FY2018 · $1.48MRoyalty · FY2018 · $1.34MFY2019Customer Service Contracts · FY2019 · $406.00KNon Cash Royalty Revenue · FY2019 · $5.03MRoyalty · FY2019 · $4.45MFY2020Customer Service Contracts · FY2020 · $198.00KNon Cash Royalty Revenue · FY2020 · $886.00KRoyalty · FY2020 · $2.96MFY2021Customer Service Contracts · FY2021 · $13.00KNon Cash Royalty Revenue · FY2021 · $879.00KFY2022Non Cash Royalty Revenue · FY2022 · $107.00KFY2023Grant · FY2023 · $3.50MNon Cash Royalty Revenue · FY2023 · $3.92MFY2024
LineFY2024ShareChange
Grant$0.00—−100.0%
Customer Service Contracts———
Government Contract———
Non Cash Royalty Revenue———
Royalty———
Total$28.70M

From the 10-K filed Mar 20, 2025VXRT

Biological products, except diagnostic substances

Vaxart, Inc. is the 22nd largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR